[ET Net News Agency, 17 February 2023] CHINARES PHARMA (03320) rose 5.29% to HK$6.57.
It hits an intra-day high of HK$6.57, hitting an 1-month high, and an intra-day low of
HK$6.25. The total shares traded was 3.65 million, with a value of HK$23.59m. The active
buy/sell ratio is 71:29, with net buying turnover of HK$9.83m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$602,864, with volume weighted
average price of HK$6.441. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$2.02m, with volume weighted average price of HK$6.483.
The stock has risen a combined 6.48% over the past 2 consecutive trading days.
Basic Information
=================
--------------------------------
Nominal 6.570 % Chg +5.29%
High 6.570 Low 6.250
Shares Tr 3.65m Turnover 23.59m
10-D SMA 6.159 %H.V 26.932
20-D SMA 6.078 VWAP 6.462
50-D SMA 6.237 RSI14 66.192
--------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 71:29, with net buying turnover
of HK$9.83m, rising a combined 6.48% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CHINARES PHARMA (03320) 6.57 +5.29
ALI HEALTH (00241) 5.92 +0.34
SINO BIOPHARM (01177) 4.25 +0.24
INNOVENT BIO (01801) 40.45 +0.12
JXR (01951) 6.51 +0.46
WUXI BIO (02269) 56.70 -1.99
JD HEALTH (06618) 56.90 -0.26
AKESO-B (09926) 42.80 +0.94
ALPHAMAB-B (09966) 13.90 +1.02
INNOCARE-B (09969) 9.11 +2.94
-----------------------------------------------
(ed)